Does reducing a patient's CRP levels with statin therapy reduce their risk of recurrent cardiovascular events?

article
Kluft, C.
Chemicals / CAS: atorvastatin, 134523-00-5, 134523-03-8; C reactive protein, 9007-41-4; pravastatin, 81131-74-0
Topics




























Biomedical ResearchC-reactive proteinCardiovascular riskLDL cholesterolStatinsantibiotic agentatorvastatinC reactive proteinhydroxymethylglutaryl coenzyme A reductase inhibitorlow density lipoprotein cholesterolplacebopravastatincardiovascular diseasecholesterol blood levelclinical trialdrug mechanismdrug responsefollow upgenetic variabilitygenotypehumanoutcomes researchpriority journalprospective studyprotein blood levelrecurrent diseaserisk assessmentrisk reductionshort survey
TNO Identifier
238465
Repository link
https://resolver.tno.nl/uuid:c6684b24-d5b7-4982-9ca1-2ef0ead8b5df
DOI
https://dx.doi.org/10.1038/ncpcardio0196
ISSN
17434297
Source
Nature Clinical Practice Cardiovascular Medicine, 2(5), pp. 244-245.
Pages
244-245
Files
To receive the publication files, please send an e-mail request to TNO Repository.